From California to Massachusetts and Florida to Illinois, CBD class action suits have been sweeping the country in recent months. One subset of these suits allege, based on state law claims like false advertising, that CBD companies are shortchanging their customers by using product labels that overstate the amount of CBD in their gummies, tinctures, and all manner of other CBD products. Meanwhile, as these suits are being litigated, the FDA is engaged in the process of determining how to regulate CBD products and what standards will apply to CBD products.
Please see full publication below for more information.
